Vancomycin induced thrombocytopenia (VIT) is an uncommon side effect of vancomycin which can manifest from mild petechiae to life-threatening bleed. Decreased renal clearance of vancomycin results in prolonged thrombocytopenia by antibody-mediated platelet destruction in the presence of vancomycin. Improvement in thrombocytopenia is achieved with the elimination of vancomycin. We describe a patient with end stage renal disease who experienced a protracted course of thrombocytopenia from vancomycin. We illustrate the mechanism of thrombocytopenia and the treatment modalities used by us and those described in literature. VIT is an important differential in patients with thrombocytopenia admitted to the hospital.
CITATION STYLE
Ajit, N. E., Devarashetty, S. P., & Master, S. (2019). Vancomycin Induced Thrombocytopenia - Protracted Course in a Hemodialysis Patient. Case Reports in Oncology, 12(3), 749–754. https://doi.org/10.1159/000503418
Mendeley helps you to discover research relevant for your work.